• Aucun résultat trouvé

[PDF] Top 20 Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease

Has 10000 "Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease" found on our website. Below are the top 20 most common "Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease".

Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease

Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease

... occurrence of premature treatment termination among 73 Trypanosoma cruzi–infected patients treated with nifurtimox in Geneva, ...living in Geneva with very low socio- ... Voir le document complet

7

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy

... Investigation in Immunology (iii), INCT, São Paulo, Brazil, 5 Department of Bioengineering, Brazil University, São Paulo, Brazil Chagas disease is caused by infection with the protozoan ... Voir le document complet

15

Opioid drug use in emergency and adverse outcomes among patients with chronic obstructive pulmonary disease: a multicenter observational study

Opioid drug use in emergency and adverse outcomes among patients with chronic obstructive pulmonary disease: a multicenter observational study

... the safety of non-palliative opioid administration to chronic obstructive pulmonary disease (COPD) patients punctually treated for an acute ...All patients over 40 presenting at ... Voir le document complet

9

Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases

Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases

... effect in a minority of patients given ACE inhibitors is cough, an effect that does not occur with angiotensin ...Data in adult patients with kidney dis- eases have shown ... Voir le document complet

7

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

... described in the reference safety information for the drug, have been attributed to the vasodilatory properties of riociguat [ 21 ...quency of AEs or SAEs did not differ greatly between ... Voir le document complet

11

Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease

Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease

... blockade and haemodilution tolerance 385 is not a likely reason to explain the lack of increase in cardiac index during ...incidence of myocardial infarction within 6 months before ... Voir le document complet

5

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.

... - In case of contraindication to metformin (CL CR between 30-45 ml/min but at risk of destabilisation or CL CR < 30 ml/min), the physician may chose a DPP-4 inhibitor rather than a sulfonylurea ... Voir le document complet

48

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

... Introduction Chronic obstructive pulmonary disease (COPD) is a common and costly disease worldwide, and the associated disease burden is projected to rise [ 1 ...part of ... Voir le document complet

12

Whole genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of Chronic Chagas disease Cardiomyopathy

Whole genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of Chronic Chagas disease Cardiomyopathy

... role in the regulation of expression of pathogenically relevant genes in CCC myocardium, and identify novel potential disease pathways and therapeutic targets in ... Voir le document complet

10

Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.

Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.

... activity and the staining intensity of DPP-4 in liver are correlated with histopathologic grade of NASH and ...candidate with several potential functions in NASH ... Voir le document complet

32

Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease : Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)

Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease : Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)

... 22,23 in relatively small groups of patients suggested that the benefit of revascularization in elderly symptom- atic patients tends to be greater and, therefore, cost- ... Voir le document complet

9

Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab

Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab

... scans in general every two to four cycles ( Table 1 ...definitions of LVSD and symptomatic HF were used across the studies included in the current analysis, data were reassessed to identify ... Voir le document complet

10

Biosensors to diagnose Chagas disease: A review

Biosensors to diagnose Chagas disease: A review

... deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions in France or abroad, or from public or private research ... Voir le document complet

18

Prevalence of sarcopenia in patients with chronic inflammatory rheumatic diseases

Prevalence of sarcopenia in patients with chronic inflammatory rheumatic diseases

... aims of this study were to assess the prevalence of osteoporosis in Albanian postmenopause women and the role of risk factors in ...conducted in Tirana city in a ... Voir le document complet

1

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

... cancer, with more than 75% of patients not eligible for surgery at diagnosis ...Because of its highly invasive character, it is the leading cause of cancer-related deaths worldwide ... Voir le document complet

8

Helium-oxygen decreases inspiratory effort and work of breathing during pressure support in intubated patients with chronic obstructive pulmonary disease

Helium-oxygen decreases inspiratory effort and work of breathing during pressure support in intubated patients with chronic obstructive pulmonary disease

... most in those patients who had the highest initial levels of hypercapnia [16], a finding which has subsequently been confirmed by Jaber et ...[15]. In the present study the patients ... Voir le document complet

7

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

... trial of adalimumab monotherapy performed between January 2000 and June ...Europe and Australia) and research commit- tees (in Canada) approved the trial at their respective study ... Voir le document complet

9

Amazonian Triatomine Biodiversity and the Transmission of Chagas Disease in French Guiana: In Medio Stat Sanitas

Amazonian Triatomine Biodiversity and the Transmission of Chagas Disease in French Guiana: In Medio Stat Sanitas

... because of their preferential relationship with armadillo species [ 91 ], while Rhodnius were pre- dominantly associated with Didelphis and TcI [ 91 , 92 ...infestation of houses by ... Voir le document complet

24

Insecticide resistance of Triatoma infestans (Hemiptera, Reduviidae) vector of Chagas disease in Bolivia

Insecticide resistance of Triatoma infestans (Hemiptera, Reduviidae) vector of Chagas disease in Bolivia

... level in the population is high. Villages in the Tarija Department (South Bolivia) exhibited the higher levels of resistance (generally RR>150) and correlates to the lower percentages ... Voir le document complet

24

Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus

Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus

... Discoid lupus erythematosus-like skin lesions in an autosomal form of chronic granulomatous disease. Strate M, Brandrup F, Wang P[r] ... Voir le document complet

5

Show all 10000 documents...